Systemic Inflammatory Markers Combined with Tumor-Infiltrating Lymphocyte Density for the Improved Prediction of Response to Neoadjuvant Chemoradiotherapy in Rectal CancerRyuichiro Sawada, Yosuke Fukunaga, Toshiki Mukai et al.|Annals of Surgical Oncology|2021Cited by 22
Tumor-Infiltrating PD-1+ Immune Cell Density is Associated with Response to Neoadjuvant Chemoradiotherapy in Rectal CancerYusuke Kitagawa, Hiroshi Kawachi, Takashi Akiyoshi et al.|Clinical Colorectal Cancer|2022Cited by 16